1NavaiTo-Gonzdlez JF, Mora-Ferndndez C, Muros de Fuentes M, et al. Inflammatory molecules and pathways in the pathogenesis of diabeticnephropathy[ J]. Nat Rev Nephrol,2011 ;7(6) :327-40.
2Fieghen HE,Friedrieh JO,Burns KE,et al. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury[ J]. BMC Nephrol,2010; 25(11) :32.
4Kikkawa R,Koya D,Haneda M.Progression of diabetic nephropathy[J].Am J Kidney Dis,2003,41(3):19～21.
5Kimmmel PL,Varela MP,peterson BA,et al.Interdialytic weight gain and survival in hemodialysis patients:effects of duration of ESRD and diabet semillitus[J].Kidney Int,2000,57(3):11.
6Mohammad A.Hemodilysis in diabetic patients[J].Am Kidney Dis,2001,38(4):5195～5199.
7Berbece AN,Richardson PM.Sustained low-efficiency dialysis in the ICU:cost,anticoagulation,and solute removal[J].Kidney Int,2006,70:963-968.
8Beltomo R,Cass A,Cole L,et al.Intensity of continuous renal-replacement therapy in critically ill patients[J].N Engl J Med,2009,361:1627-1638.
9Palevsky PM,Zhang JH,O'Connor TZ,et al.Intensity of renal support in critically ill patients with acute kidney injury[J].N Engl J Med,2008,359:7-20.
10Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31:1250-1256.
